EP BIOCOMPOSITES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161 INR | -2.69% |
|
-2.39% | -14.54% |
| Feb. 01 | EP Biocomposites Bags INR49 Million Order for Intermediate Sewerage Pumping Stations, Raising Main | MT |
| 2023 | EP Biocomposites to Build Sewage Treatment Plant for Oil & Natural Gas Corp. | MT |
Valuation
| Fiscal Period: March | 2023 |
|---|---|
| Capitalization 1 | 338.8 |
| Enterprise Value (EV) 1 | 329.7 |
| P/E ratio | 51.1 x |
| Yield | - |
| Capitalization / Revenue | 4.75 x |
| EV / Revenue | 4.62 x |
| EV / EBITDA | 30,766,283 x |
| EV / FCF | 37,423,784 x |
| FCF Yield | 0% |
| Price to Book | 4.03 x |
| Nbr of stocks (in thousands) | 1,682 |
| Reference price 2 | 201.5 |
| Announcement Date | 8/18/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 34.1 | 29.48 | 80.6 | 71.31 |
| EBITDA | - | 4.601 | 13.83 | 10.72 |
| EBIT 1 | 2.592 | 4.598 | 13.17 | 9.721 |
| Operating Margin | 7.6% | 15.6% | 16.34% | 13.63% |
| Earnings before Tax (EBT) 1 | 2.592 | 4.642 | 11.66 | 8.14 |
| Net income 1 | 1.896 | 3.58 | 8.094 | 5.761 |
| Net margin | 5.56% | 12.14% | 10.04% | 8.08% |
| EPS | - | 9.547 | 9.480 | 3.940 |
| Free Cash Flow | - | -0.1752 | -48.59 | 8.81 |
| FCF margin | - | -0.59% | -60.28% | 12.36% |
| FCF Conversion (EBITDA) | - | - | - | 82.21% |
| FCF Conversion (Net income) | - | - | - | 152.93% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 2/2/22 | 2/2/22 | 8/18/23 | 8/18/23 |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | 39.6 | - |
| Net Cash position 1 | 1.13 | 1.48 | - | 9.1 |
| Leverage (Debt/EBITDA) | - | - | 2.86 x | - |
| Free Cash Flow | - | -0.18 | -48.6 | 8.81 |
| ROE (net income / shareholders' equity) | - | 172% | 67.9% | 11.1% |
| ROA (Net income/ Total Assets) | - | 30.6% | 15.5% | 5.79% |
| Assets 1 | - | 11.68 | 52.13 | 99.57 |
| Book Value Per Share | - | 10.30 | 17.10 | 50.00 |
| Cash Flow per Share | - | 3.940 | 1.330 | 13.00 |
| Capex | - | 0.03 | 4.74 | 0.22 |
| Capex / Sales | - | 0.09% | 5.88% | 0.31% |
| Announcement Date | 2/2/22 | 2/2/22 | 8/18/23 | 8/18/23 |
1INR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -14.54% | 3.24M | |
| +8.46% | 39.14B | |
| +4.17% | 31.88B | |
| +29.73% | 19.24B | |
| -10.42% | 18.25B | |
| +3.22% | 15.25B | |
| +2.04% | 9.18B | |
| -11.57% | 8.42B | |
| +36.77% | 7.44B | |
| +1.51% | 7.17B |
- Stock Market
- Equities
- 543595 Stock
- Financials EP Biocomposites Limited
